<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>Accumulating evidence indicates that cyclooxygenase (COX)-2-derived <z:chebi fb="11" ids="26333">prostaglandin</z:chebi> (PG) E(2) is involved in the development of various <z:e sem="disease" ids="C0027651" disease_type="Neoplastic Process" abbrv="">tumors</z:e>, including <z:e sem="disease" ids="C1527249,C0009402" disease_type="Neoplastic Process" abbrv="">colorectal cancer</z:e> </plain></SENT>
<SENT sid="1" pm="."><plain>However, the precise contribution of microsomal <z:chebi fb="0" ids="26338">PGE</z:chebi> synthase (mPGES)-1, a terminal enzyme that acts downstream of COX-2 in the <z:chebi fb="0" ids="26338">PGE</z:chebi>(2)-biosynthetic pathway, to multiple processes of <z:e sem="disease" ids="C0027651" disease_type="Neoplastic Process" abbrv="">tumor</z:e> development is not yet fully understood </plain></SENT>
<SENT sid="2" pm="."><plain>Here, we show the pro-tumorigenic role of mPGES-1 in chemical carcinogen-induced colon <z:e sem="disease" ids="C0596263" disease_type="Neoplastic Process" abbrv="">carcinogenesis</z:e> and intrasplenic <z:e sem="disease" ids="C0027651" disease_type="Neoplastic Process" abbrv="">tumor</z:e> transplantation models </plain></SENT>
<SENT sid="3" pm="."><plain>Genetic deletion of mPGES-1 significantly reduced both the total number and size of colorectal <z:mpath ids='MPATH_491'>polyps</z:mpath> at 18 weeks after azoxymethane administration with reduced nuclear translocation of β-catenin, altered expression profiles of chemokines/cytokines and increased production of antitumorigenic PGs, <z:chebi fb="11" ids="26333">prostaglandin</z:chebi> D(2) and prostacyclin in <z:e sem="disease" ids="C0027651" disease_type="Neoplastic Process" abbrv="">tumor</z:e> tissues </plain></SENT>
<SENT sid="4" pm="."><plain>At an early stage (6 weeks), mPGES-1 deficiency significantly reduced the number of <z:mpath ids='MPATH_557'>aberrant crypt foci</z:mpath>, while its transgenic overexpression increased the number </plain></SENT>
<SENT sid="5" pm="."><plain>Furthermore, the growth of intrasplenically transplanted <z:e sem="disease" ids="C0027651" disease_type="Neoplastic Process" abbrv="">tumor</z:e> cells was suppressed in mPGES-1 knockout (KO) mice </plain></SENT>
<SENT sid="6" pm="."><plain>Co-culture of <z:e sem="disease" ids="C0027651" disease_type="Neoplastic Process" abbrv="">tumor</z:e> cells with bone marrow-derived macrophages (BM-MΦs) isolated from <z:mp ids='MP_0002169'>wild-type</z:mp> (WT) mice resulted in the induction of mPGES-1 in BM-MΦs and increased the growth of <z:e sem="disease" ids="C0027651" disease_type="Neoplastic Process" abbrv="">tumor</z:e> cells in vitro, whereas mPGES-1-null BM-MΦs failed to facilitate <z:e sem="disease" ids="C0598934" disease_type="Neoplastic Process" abbrv="">tumor growth</z:e> </plain></SENT>
<SENT sid="7" pm="."><plain>The adoptive transfer of WT BM-MΦs into mPGES-1 KO mice restored the growth of transplanted <z:e sem="disease" ids="C0027651" disease_type="Neoplastic Process" abbrv="">tumor</z:e> cells, indicating that mPGES-1 in MΦs is important for the growth of adjacent <z:e sem="disease" ids="C0027651" disease_type="Neoplastic Process" abbrv="">tumor</z:e> cells </plain></SENT>
<SENT sid="8" pm="."><plain>Taken together, our findings suggest that the inhibition of mPGES-1 is an alternative therapeutic target for colorectal and possibly other <z:e sem="disease" ids="C1306459,C0006826" disease_type="Neoplastic Process" abbrv="">cancers</z:e> </plain></SENT>
</text></document>